May 27, 2020   SOURCE: BusinessWire

Global Fill Finish Manufacturing Industry (2020 to 2025) - The COVID-19 Outbreak Has Positively Impacted the Market - ResearchAndMarkets.com

The "Fill Finish Manufacturing Market by Product (Consumables (Prefilled Syringes (Glass, Plastic), Vial), Instruments (Systems (Stand Alone, Integrated), Machine Type (Automated, Manual)), End User (CMO, Biopharmaceutical Company) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The fill-finish manufacturing market is projected to reach USD 12.09 billion by 2025 from USD 7.51 billion in 2020 at a CAGR of 10.0% during the forecast period.

Rising technological advancements in fill-finish manufacturing processes is a major factor expected to drive the overall growth of the fill-finish manufacturing market.

The major factors driving the growth of this market include rising technological advancements in fill-finish manufacturing processes, the growth of the biopharmaceutical industry, and the rising adoption of prefilled syringes for parenteral dosage forms. However, the high costs associated with isolators or restricted access barrier systems (RABS) is a factor expected to limit the growth of this market.

The prefilled syringes segment is expected to grow at the highest CAGR during the forecast period in the fill-finish manufacturing market.

The consumables segment is segmented broadly into prefilled syringes, vials, cartridges, and other consumables such as ampoules, bottles, and IV bags. The prefilled syringes sub-segment is projected to grow at the highest CAGR during the forecast period. This is mainly due to its advantages such as ease of administration, time & accuracy benefits, safety, convenience, lower cost, and biologic sterility.

The automated machines segment, by machine type segment, is expected to grow at the highest CAGR during the forecast period.

Based on machine type, the instrument segment is divided into automated machines and semi-automated and manual machines. Automated machines reduce the risks of contamination due to limited human interaction. They have helped organizations reduce the cost of maintenance, labor overheads, and increase overall productivity for fill-finish manufacturing processes.

The Asia Pacific accounts for the largest share of the global fill-finish manufacturing market during the forecast period.

The Asia Pacific is expected to be the fastest-growing segment during the forecast period. Factors such as increasing investments by CMOs & key biopharmaceutical players in Asian countries, increasing government support, developments in R&D infrastructure, and growing expertise & academic excellence in the APAC region are driving the market growth.

Market Dynamics

Drivers

  • Rising Technological Advancements in Fill-Finish Manufacturing Processes
  • Growth of the Biopharmaceutical Industry
  • Rising Adoption of Prefilled Syringes for Parenteral Dosage Forms

Restraints

  • High Costs Associated with Isolators/Rabs

Opportunities

  • Emerging Markets

Challenges

  • Challenges Associated with Maintaining Sterility in Fill-Finish Manufacturing Operations

Trends

  • Growing Outsourcing of Fill-Finish Operations
  • The COVID-19 Outbreak Has Positively Impacted the Fill-Finish Manufacturing Market

Companies Profiled

  • Becton, Dickinson and Company (Bd)
  • Syntegon Technology Gmbh
  • I.M.A. Industria Macchine Automatiche S.P.A
  • Stevanato Group
  • West Pharmaceutical Services
  • Optima Packaging Group Gmbh
  • Bausch + Strobel
  • Groninger & Co. Gmbh
  • Sgd Pharma
  • Schott Ag
  • Gerresheimer Ag
  • Nipro
  • Bausch Advanced Technologies Group
  • Vanrx Pharmasystems Inc.
  • Maquinaria Industrial Dara, Sl
  • Marchesini Group S.P.A.
  • Steriline S.R.L.
  • AST
  • Reagent Chemical & Research, Inc.
  • Aseptic Technologies

For more information about this report visit https://www.researchandmarkets.com/r/qy4gq8